Grant-Huerta Yanina
Chief Financial Officer
Grant-Huerta Yanina has filed 5 SEC Form 4 filings (11 transaction rows) across 2 companies, including IMA, ATRA, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 17, 2026.
On the most recent filing, Grant-Huerta Yanina is listed as Chief Accounting Officer at Atara Biotherapeutics, Inc. Inside the rolling window, Grant-Huerta Yanina reported no open-market purchases and 3 open-market sales totaling $57K in ATRA. The largest disclosed transaction in the window is a sale of 1,804 ATRA shares on Nov 17, 2025, worth $24K.
Companies traded
Other insiders at IMA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$57K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Grant-Huerta Yanina made?
Grant-Huerta Yanina has filed 5 SEC Form 4 filings (11 transaction rows) across 2 companies, including IMA, ATRA since 2025.
Which companies does Grant-Huerta Yanina trade?
Grant-Huerta Yanina has filed SEC Form 4 disclosures for 2 companies, including IMA, ATRA.
When was Grant-Huerta Yanina's most recent SEC Form 4 filing?
Grant-Huerta Yanina's most recent SEC Form 4 filing on Tracefour is dated Aug 17, 2026.
What is Grant-Huerta Yanina's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Grant-Huerta Yanina is listed as Chief Financial Officer.
What is Grant-Huerta Yanina's total buy and sell value in the current window?
Inside the rolling retention window, Grant-Huerta Yanina bought $0 and sold $57K based on SEC Form 4 filings.
What was Grant-Huerta Yanina's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,804 ATRA shares on 2025-11-17, worth $24K, per SEC Form 4 filings.